Concepedia

Chelsea M. Byrd

CM

Statistics

Publications

19

Citations

1.2K

H-Index

16

Active since

1965

Affiliations

Siga Technologies (United States)(Current)

Oregon State University

United States Department of the Army

Heidelberg University

United States Army Medical Research Institute of Infectious Diseases

Chelsea M. Byrd is an author at Siga Technologies (United States) specializing in virology, life sciences, and molecular virology.

Publications per year

1965–2014

19

Publications

19

Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246

John W. Huggins, Arthur J. Goff, Lisa E. Hensley et al. · Antimicrobial Agents and Chemotherapy · 2009 · 176 citations · Full text

, , +16

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach et al. · Antimicrobial Agents and Chemotherapy · 2012 · 164 citations · Full text

, , +17

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Robert Jordan, Arthur J. Goff, Annie Frimm et al. · Antimicrobial Agents and Chemotherapy · 2009 · 136 citations · Full text

, , +17

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu et al. · Antimicrobial Agents and Chemotherapy · 2013 · 112 citations · Full text

, , +17

Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor

Pietro Scaturro, Iuni Margaret Laura Trist, David Paul et al. · Journal of Virology · 2014 · 97 citations · Full text

, , +17

1–5 of 19